implantable abdominal vagus nerve stimulator; Maestro Rechargeable System
Jump to navigation
Jump to search
Indications
- treatment of obesity
- adults >= 18 years
- BMI of 35-45
- >= 1 obesity-related condition (i.e. type 2 diabetes)
- weight-loss programs have been ineffective
Adverse effects
Procedure
- surgically implanted into the abdomen
- implant emits electric pulses that block the vagus nerve*
* the vagus nerve signals stomach emptiness & fullness to the brain
Notes
- achieves < 10% weight loss[1]
More general terms
References
- ↑ 1.0 1.1 FDA News Release. January 14, 2015 FDA approves first-of-kind device to treat obesity http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm430223.htm